Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway
<p>Cisplatin is a widely used chemotherapeutic agent for treatment of various cancers. However, treatment with cisplatin is associated with drug resistance and several adverse side effects such as nephrotoxicity, reduced immunity towards infections and hearing loss. A Combination of cisplatin...
Saved in:
| Main Author: | Iman W. Achkar (4246141) (author) |
|---|---|
| Other Authors: | Nabeel Abdulrahman (725914) (author), Hend Al-Sulaiti (14153271) (author), Jensa Mariam Joseph (14151351) (author), Shahab Uddin (154400) (author), Fatima Mraiche (14151369) (author) |
| Published: |
2018
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted
by: Reem Ali (9913494)
Published: (2022) -
Characterization of the Cytotoxic Mechanism and Mode of Cell Death Induced by a MEK1/2-selective version of Anthrax Lethal Toxin (PrAg/LFW271A) in Acute Myeloid Leukemia
by: Mroue, Zeinab
Published: (2023) -
Targeting the MAP Kinase pathway in human acute myeloid leukemia cells using a recombinant anthrax lethal toxin. (c2013)
by: Kassab, Elias
Published: (2013) -
Characterization of the Potency and Mechanism of Action of a Novel Dual-Selective Intermolecularly Complemented Version of Anthrax Lethal Toxin (PAU2R200A- PAL1I207R/FP59) in Breast Cancer
by: Basala, Sobhiya
Published: (2023) -
Protein kinase C inhibitor Gö6976 but not Gö6983 induces the reversion of E- to N-cadherin switch and metastatic phenotype in melanoma: identification of the role of protein kinase D1
by: Messaouda Merzoug-Larabi (3619421)
Published: (2017)